Burning Rock Biotech (BNR) Income from Continuing Operations (2020 - 2025)
Historic Income from Continuing Operations for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.
- Burning Rock Biotech's Income from Continuing Operations rose 5443.72% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.1 million, marking a year-over-year increase of 7454.97%. This contributed to the annual value of -$45.9 million for FY2024, which is 4980.47% up from last year.
- Latest data reveals that Burning Rock Biotech reported Income from Continuing Operations of -$2.3 million as of Q3 2025, which was up 5443.72% from -$1.3 million recorded in Q2 2025.
- Burning Rock Biotech's Income from Continuing Operations' 5-year high stood at -$1.3 million during Q2 2025, with a 5-year trough of -$41.2 million in Q1 2022.
- In the last 5 years, Burning Rock Biotech's Income from Continuing Operations had a median value of -$23.9 million in 2023 and averaged -$21.6 million.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first tumbled by 20865.07% in 2021, then soared by 9131.9% in 2025.
- Quarter analysis of 5 years shows Burning Rock Biotech's Income from Continuing Operations stood at -$39.8 million in 2021, then grew by 22.56% to -$30.8 million in 2022, then grew by 26.79% to -$22.5 million in 2023, then skyrocketed by 57.06% to -$9.7 million in 2024, then skyrocketed by 76.29% to -$2.3 million in 2025.
- Its last three reported values are -$2.3 million in Q3 2025, -$1.3 million for Q2 2025, and -$1.8 million during Q1 2025.